The test uses the company's SIA platform, a protein biomarker technology that measures different protein isoform populations to assess patient disease states.
Through studies of individuals with an inherited cancer predisposition syndrome, researchers identified germline mutations contributing to sporadic thyroid cancer as well.
The Precision Medicine Exchange Consortium will bring together cancer research institutions to share information and promote genomic profiling in treatment.
The partners will use Watson's cognitive capabilities to reduce to minutes from weeks the translation of DNA information to create a genetic profile of a patient.
Besides optimizing open-source code, the company has forged focused partnerships with multiple bioinformatics firms including Edico Genome and Curoverse.
NEW YORK (GenomeWeb) – IBM said today that it has partnered with the Cleveland Clinic to evaluate the use of its Watson supercomputer in a personalized oncology program at the clinic.
NEW YORK (GenomeWeb) – Cleveland Clinic and University Hospitals have received a $1 million donation to support genome sequencing for cancer patients across the Northeast Ohio region.
A team comprising researchers from Genomic Health and the Cleveland Clinic have published a study describing the analytical validation of Oncotype DX prostate, the company's RT-PCR-based gene expression assay intended to predict prostate cancer aggressiveness and severity from fi
The Cleveland Clinic is beginning a study to assess the feasibility and clinical impact of using targeted sequencing, provided by Foundation Medicine, to guide cancer care for patients with a variety of solid tumors.
